This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 45 and 65
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Hypoestrogenism, common in menopause, is responsible for systemic and metabolic changes affecting women's wellness, favoring hot flashes, urogenital atrophy and bone mass loss. Hormone reposition therapy (HRT) with estrogen or estrogen associated to progesterone is administered to minimize these effects. Meanwhile, the beneficial effects of HRT are known, there is still concern about its adverse effects such as thromboembolic and cardiovascular effects, increased risk of breast and endometrial cancer. Thus, there is an increasing interest in the development of phytohormonal HRT. The aim of the investigators' study is to evaluate the effects of concentrated extract of soy on hypercoagulation markers in menopausal women.

Provided treatments

  • Drug: Isoflavone
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT00925639. The sponsor of the trial is Federal University of São Paulo and it is looking for 84 volunteers for the current phase.
Official trial title:
Effects of the Concentrated Extract of Soy on Coagulation Factors After Menopause